Navigation Links
Helix BioPharma Corp. Announces Fiscal 2009 Results
Date:10/29/2009

study is expected to complete the minimum 12 patients by the end of the third quarter of fiscal 2010.
  • Enrollment in the ongoing Phase II clinical trial of Topical Interferon Alpha-2b in patients with anogenital warts ("AGW") in Sweden and Germany is progressing on track. The Company expects the last patient to be enrolled on or around the end of the first quarter of fiscal 2010. The study has now enrolled over 93% of the required 120 patients.
  • Financing

    • Completed a private placement financing on October 2, 2008 for gross proceeds of $11,424,000.
    • Completed a private placement financing on September 8, 2009 for gross proceeds of $13,581,250.
    • Prof. Majewski, stepped down from the Board of Directors to assume the advisory role of European medical director, effective August 11, 2009.
    • Prof. Kazimierz Roszkowski-Sliz was appointed to the Board of Directors on August 17, 2009.

    FINANCIAL REVIEW

    For fiscal 2009, the Company recorded a net loss of $14,102,000, which represents an increase of $7,138,000 when compared to fiscal 2008. The net loss per common share for fiscal 2009 was $0.27 and represents an increase of $0.11 in loss per common share when compared to fiscal 2008. Product revenue contributed to the increase in revenue in fiscal 2009 and overall expenses were higher when compared to fiscal 2008 which mainly reflect higher research and development expenditures, stock-based compensation expense associated with stock options granted in the second quarter, lower interest income and a foreign exchange loss.

    Total revenues in fiscal 2009 were $3,841,000 and represent an increase of $250,000 or 7.0% when compared to total revenues in fiscal 2008 of $3,591,000. Product revenue contributed to the increase in revenue in fiscal 2009 when compared to fiscal 2008 and was offset slightly by a decrease in license fees and royalties.


    '/>"/>
    SOURCE Helix BioPharma Corp.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
    2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
    3. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
    4. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
    5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
    6. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
    7. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
    8. PDL BioPharma Completes October 1 Special Dividend Payment
    9. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
    10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
    11. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... -- This test can detect HIV infection if used 3 ... activities that can transfer body fluids from one person to ... needles. , An in-vitro diagnostic home-use test for ... works by looking for your body,s response to fighting the ... patients to learn their status in a single visit and ...
    (Date:9/23/2014)... Research and Markets ( ... the  "Large Volume Wearable Injectors - 2nd ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... potential for the future. From the conventional ... the modern-day pre-filled syringes, pen-injectors, needle free ...
    (Date:9/23/2014)... Rising health concerns, growing ... number of foreign and domestic players in the market ... India   The India Probiotic ... growth potential markets worldwide due to multiple factors such ... youth, changing food consumption patterns, increasing diabetic population, growing ...
    Breaking Medicine Technology:WholeHealth Products announces the release of the FDA Cleared "HIV 1&2" Rapid Diagnostic Test for Professional and Retail 2Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3
    ... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today that ... notes. The Company intends to use the ... of the outstanding borrowings under its credit facility and for ... Smith Incorporated, BNP Paribas Securities Corp. and RBS Securities Inc. ...
    ... 7, 2011 Vermillion, Inc. (NASDAQ: ... to present at the Stephens Fall Investment Conference. The conference ... New York City on November 15-16, 2011. Vermillion,s ... Wednesday, November 16, 2011 at 10:30 a.m. Eastern time, with ...
    Cached Medicine Technology:Zimmer Holdings, Inc. Announces Offering of Senior Notes 2Vermillion to Present at Stephens Fall Investment Conference on November 16, 2011 2
    (Date:9/23/2014)... The University of California, Davis, and Academia Sinica, ... China (Taiwan), have entered into a collaborative agreement ... program that couples cutting-edge research with opportunities to ... new companies. , The agreement was signed Sept.12 ... research at UC Davis and President Chi-Huey Wong ...
    (Date:9/23/2014)... Dallas, TX (PRWEB) September 23, 2014 ... be taken before making a purchase. It’s difficult to ... and it’s easy for them to manipulate their customers ... mitigate this dilemma, but they tend to lack in ... Consumer Health Reports was founded to fix this ...
    (Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- A test used ... geographic regions where certain lung infections are more common, a ... lung cancer is through the use of what,s known as ... imaging called FDG-PET is used, according to the study authors. ... do parts of the lungs that don,t have ...
    (Date:9/23/2014)... DC (PRWEB) September 23, 2014 ... care? The National Quality Forum (NQF) released ... ( http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=77687 ), and an infographic ( http://bit.ly/1tX3lzA ... rising cost of healthcare, how patients define affordability, ... consumers to get the best possible healthcare at ...
    (Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- The ... unapproved prescription drugs is growing, so doctors need ... Food and Drug Administration warned Tuesday. In ... so widespread that it has launched a program ... and administrators about proper drug purchasing procedures. The ...
    Breaking Medicine News(10 mins):Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2Health News:Finding Affordable Care: Asking the Right Question is Key 2
    ... Laura Rogers, project director for the Pew Campaign ... following statement regarding the U.S. Food and Drug Administration,s ... of certain antibiotics in animal agriculture: , ... animal agriculture helps fuel the increase in antibiotic-resistant infections ...
    ... Insurance,Company (John Hancock) is reinforcing its commitment to ... requirements through an,affiliation with the ClearCert Clearinghouse. ... the year and effective January 1, 2009,will only ... Since beginning ...
    ... (The Dignity of a Person), an Instruction from the Vatican ... issues arising from biomedical research, provides guidance on how to ... age, said Cardinal Francis George of Chicago, president of the ... , "We welcome the Instruction as theologians, medical ...
    ... calcium and vitamin D in fight against osteoporosis, study finds ... of protein and cereal grains causes excess acid production in ... result in weakened bones. , However, a new study finds ... plenty of fruits and vegetables can strengthen bones. , The ...
    ... 12 Bionovo, Inc.,(Nasdaq: BNVI ) will ... agent BN108 at the 31st Annual San Antonio Breast ... Center, San Antonio TX,December 10-14, 2008. , ... the pathway for cancer cell,apoptosis (cell death) induced by ...
    ... Chronic Hepatitis and Liver Diseases for not only treatment & diagnosis ... , ... (PRWEB) December 12, 2008 -- This year, from ... held the 2008 International Symposium on Chronic Hepatitis and ...
    Cached Medicine News:Health News:Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administration's Reversal on Antibiotics Safeguards in Animal Farming 2Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 2Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 3Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 2Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 3Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 4Health News:Fruits and Veggies May Strengthen Bones 2Health News:Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium 2Health News:ITRI: Taiwan Focuses on C Liver Medic's R&D to Reach USD 6 Billion Potential Market in the World 2Health News:ITRI: Taiwan Focuses on C Liver Medic's R&D to Reach USD 6 Billion Potential Market in the World 3Health News:ITRI: Taiwan Focuses on C Liver Medic's R&D to Reach USD 6 Billion Potential Market in the World 4
    ... Sleepscan VISION ensures flexibility in system configuration ... VISION utilizes the powerful Netlink amplifier system, ... standard Ethernet connection. Only computer industry components ... Sleepscan VISION to take advantage of the ...
    ... From the Pioneer in Digital EEG ... Digital EEG system presents the latest ... the Ceegraph VISION. This innovative system ... remote communications and information management to ...
    ... MOBEE headboxes are ... XLTEK's line of portable ... with a robust new ... latest software, XLTEK's standard ...
    ... Slit Lamp is an all-in-one instrument for observation, ... also allows the SL 130 to be used ... the possibility of operating the slit projector in ... right hand. The instrument configuration allows you to ...
    Medicine Products: